학술논문
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study
Document Type
Article
Author
Source
In The Lancet Oncology April 2020 21(4):561-570
Subject
Language
ISSN
1470-2045